Benedicto David C.
- SEC CIK
- 0001864646
No open-market purchases or sales filed in the past year.
Current role at each company
- DMK DMK Pharmaceuticals CorpChief Financial Officeras of Mar 22, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Benedicto David C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Benedicto David C.Chief Financial Officer | SSale | −3.60K | $0.61 | −$2.20K | −8.3%39.9K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Benedicto David C.Chief Financial Officer | SSale | −13.6K | $0.79 | −$10.7K | −23.8%43.5K after |